Cytosorbents (CTSO) Reports In-Line Q3 EPS

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.86 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
• SS&C Technologies (SSNC) Tops Q2 EPS by 8c; offers guidance
• Deckers Brands (DECK) Tops Q1 EPS by 7c, Offers Guidance